Inada, Ken http://orcid.org/0000-0002-3073-4588
Enomoto, Minori http://orcid.org/0000-0001-8585-9479
Yamato, Kentaro http://orcid.org/0000-0002-5027-6289
Mishima, Kazuo http://orcid.org/0000-0003-1182-1181
Funding for this research was provided by:
Takeda Pharmaceutical Company Limited
Article History
Accepted: 6 March 2021
First Online: 13 March 2021
Declarations
:
: Takeda Pharmaceutical Company Limited (Tokyo, Japan) funded this study, assisted with the preparation of this manuscript and will sponsor open access of the published article.
: Ken Inada reports research grants from MSD and speaker’s honoraria from Eisai, Eli Lilly, Janssen, Otsuka Pharmaceutical Company, Shionogi, Mitsubishi Tanabe Pharma, Sumitomo Dainippon Pharma, Novartis, Pfizer, Meiji Seika Pharma, MSD, Yoshitomiyakuhin Corporation and Mochida Pharmaceutical Company. Minori Enomoto has no conflicts of interest that are directly relevant to the content of this article. Kentaro Yamato is an employee of Takeda Pharmaceutical Company Limited. Kazuo Mishima reports public research funds from the Japanese Ministry of Health, Labour and Welfare (H29-Seishin-Ippan-001, 19GC1012) and the Japanese Ministry of Education, Science, and Technology (19H03578), research grants from Eisai Co., Ltd., Nobelpharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd. and Takeda Pharmaceutical Co., Ltd, and speaker’s honoraria from Eisai Co., Ltd., MSD Inc., Takeda Pharmaceutical Co., Ltd., Astellas Pharma Inc., Pfizer Inc., Otsuka Pharmaceutical Co., Ltd., Mochida Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation (Yoshitomiyakuhin Corporation) and Janssen Pharmaceutical.
: This was a retrospective analysis of data within a nationwide claims database managed by Medical Data Vision Co., Ltd, Tokyo, Japan. Because of the anonymous nature of the analysis and the absence of direct patient involvement, no ethical approval or patient consent was required for the present study in the authors’ institutions. Medical Data Vision Co., Ltd collect and use patients’ personal data and anonymously processed information in accordance with regulations including the Japanese Act on the Protection of Personal Information and the European Union’s General Data Protection Regulation.
: Not applicable.
: Not applicable.
: Data used in this study are not available publicly. The anonymised insurance data, which can be used for secondary research, can be accessed upon request to MDV (ExternalRef removed).
: Not applicable.
: The authors critically reviewed all drafts of the manuscript and approved the final version for submission. KI is a psychiatric expert and was involved in the planning of the study and interpretation of the results. KM is a sleep medicine specialist and was involved in study planning and study approval. KY contributed to the development of the research plan, the management of the research and interpretation of the results. ME is a sleep assessment specialist and was involved with research planning, analytical advice and results interpretation.